NG
STJ

NatWest Group’s St Jude Medical STJ Stock Holding History

NatWest Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-23,710
Closed -$1.47M – 742
2013
Q4 		$1.47M Buy
23,710
+5,116
+28% +$296K 0.04% 325
2013
Q3 		$997K Buy
18,594
+9,140
+97% +$471K 0.03% 433
2013
Q2 		$431K Buy
+9,454
New +$410K 0.01% 624

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

NatWest Group's STJ Position: Q1 2014 in Review

NatWest Group sold out of St Jude Medical (STJ) in Q1 2014, closing a stake of 23,710 shares — an estimated $1.47M sold.

NatWest Group first reported a position in STJ in Q2 2013 and held it in 3 quarters. The position peaked at $1.47M in Q4 2013. 565 funds tracked by Wall St. Rank hold STJ as of Q1 2014.

  • NatWest Group reported no remaining St Jude Medical position as of Q1 2014 after selling out during the quarter.
  • NatWest Group sold 23,710 St Jude Medical shares in Q1 2014, an estimated $1.47M.
  • NatWest Group first reported a position in St Jude Medical in Q2 2013 and held it in 3 quarters.
  • NatWest Group's St Jude Medical position peaked at $1.47M in Q4 2013.
  • 565 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2014.

Based on NatWest Group's 13F filing for Q1 2014, filed 15 May 2014.